Competitive Grants Program
Pfizer supports the global healthcare community’s independent initiatives (e.g., research, quality improvement or education) to improve patient outcomes in areas of unmet medical need that are aligned with Pfizer’s medical and/or scientific strategies.
Pfizer’s competitive grant program involves a publicly posted Request for Proposal (RFP) that provides detail regarding a specific area of interest and sets timelines for review and approval. Organizations are invited to submit an application addressing the specific gaps in research, practice or care as outlined in the specific RFP. The grant requester (and ultimately the grantee) is responsible for the design, implementation, sponsorship, and conduct of the independent initiative supported by the grant, including compliance with any regulatory requirements.
Sign up to receive all grant announcements, including Request for Proposal (RFP) postings.
Sign Up for Alerts DetailsTitle Grant Type Focus Area Country Application Due Date Epidemiology and surveillance of Gram-negative infections caused by carbapenemase-producing organisms (CPOs) in the UKRelease Date:Research Internal Medicine United Kingdom Advancing Care for Patients with Advanced ALK+ Non-Small Cell Lung Cancer (NSCLC)Education Oncology All Quality Improvement Solutions for the Diagnosis and Management of Migraine and Headache DisordersQuality Improvement Internal Medicine Canada, USA Shared Decision Making in Hemophilia Patient CareRelease Date:Quality Improvement Rare Disease China Real-World Atopic Dermatitis: Italian Insights GrantRelease Date:Research Inflammation & Immunology Italy Evolving Treatment Options in First-Line Metastatic Urothelial Carcinoma (mUC) and Muscle Invasive Bladder Cancer (MIBC)Education Oncology All Optimizing Care for patients with Muscle Invasive Bladder Cancer (MIBC)Release Date:Quality Improvement Oncology Canada Optimizing HRRm Testing and Workflow Integration in mCSPCRelease Date:Quality Improvement, Research Oncology Canada Driving Timely Biomarker Testing to Optimize Treatment Decisions for Colorectal Cancer Patients Across CanadaRelease Date:Partner: Colorectal Cancer Canada (CCC)Quality Improvement, Research Oncology Canada Antimicrobial Stewardship —Treatment optimization under antibiotics appropriate use policy in ChinaRelease Date:Research Inflammation & Immunology China Title Grant Type Focus Area Country Application Due Date Local Level Educational Grants Program to Increase Awareness & Understanding of Transthyretin Amyloid Cardiomyopathy (ATTR-CM)Release Date:Education Rare Disease USA Quality Improvement Grants to improve the early suspicion, identification, and the management of patients with ATTR-CMRelease Date:Quality Improvement Rare Disease Canada Develop Young Physicians to Lead the Increase in Preventive Awareness by VaccinationRelease Date:Education Vaccines Japan Optimizing maternal immunization practice and vaccination access during pregnancy in ItalyRelease Date:Quality Improvement Vaccines Italy Projects for Enhancing Regional Cancer TreatmentRelease Date:Partner: Japanese Society of Clinical OncologyQuality Improvement Oncology Japan Sickle Cell Disease (SCD) FellowshipRelease Date:Fellowship Rare Disease USA Cancer RegistryRelease Date:Research Oncology Congo, The Democratic Republic The Value of Standardized Diagnosis and Treatment in Patients with Moderate-to-Severe Atopic DermatitisRelease Date:Research Inflammation & Immunology China Real World Evidence of Abrocitinib in Adolescent Patients with Moderate-to-Severe Atopic DermatitisRelease Date:Research Inflammation & Immunology China Improving the Therapeutic Environment for Metastatic Breast CancerRelease Date:Education Oncology Japan Shared Decision-Making (SDM) in Lung CancerRelease Date:Education Oncology Japan Improving Care for Patients with Hodgkin and Non-Hodgkin’s LymphomaRelease Date:Education Oncology USA